Jump Financial, LLC Evogene Ltd. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.63 - $2.83 $27,384 - $47,544	-16,800 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.45 - $3.45 $102,655 - $144,555	-41,900 Reduced 71.38%	16,800 $44,000
Q2 2021 Aug 13, 2021	BUY	$3.3 - $5.02 $11,880 - $18,072	3,600 Added 6.53%	58,700 $201,000
Q1 2021 May 17, 2021	SELL	$4.29 - $9.94 $37,323 - $86,478	-8,700 Reduced 13.64%	55,100 $278,000
Q4 2020 Feb 12, 2021	BUY	$2.41 - $5.63 $153,758 - $359,194	63,800 New	63,800 $300,000

4.08M

23K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $26.8M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.